Topic: Adderall Shortage

The United States is experiencing a significant shortage of ADHD medications like Adderall and Vyvanse, attributed to a 46% increase in prescriptions over the last decade. The surge is linked to the rise of telehealth platforms during the pandemic. Reports indicate some parents are resorting to giving their children caffeine drinks to compensate for the lack of available prescription stimulants.

The U.S. is experiencing significant shortages of Adderall and the liquid form of the antibiotic Amoxicillin. Pharmaceutical companies like Teva cite high demand and supply chain issues, while critics suggest the shortages may be a tactic for price gouging. Adderall prescriptions reportedly rose to 41 million in 2021, up from 37 million the previous year.

The FDA has confirmed a nationwide shortage of Adderall, the primary medication used to treat ADHD. Teva Pharmaceutical Industries, the largest manufacturer, cited labor shortages and a significant increase in prescriptions during the COVID-19 pandemic as the primary causes. Critics suggest the shortage may be a form of artificial price fixing by pharmaceutical companies to limit supply and drive up retail costs.